Header Logo

Connection

Nicola Klein to Child

Back to Details
This is a "connection" page, showing publications Nicola Klein has written about Child.
Nicola Klein
Connection Strength
5.181
Child
  1. Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children. Influenza Other Respir Viruses. 2024 Oct; 18(10):e70022.
    View in: PubMed
    Score: 0.148
  2. Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine. Pediatrics. 2024 Aug 01; 154(2).
    View in: PubMed
    Score: 0.146
  3. Safety of COVID-19 mRNA Vaccination Among Young Children in the Vaccine Safety Datalink. Pediatrics. 2023 Jul 01; 152(1).
    View in: PubMed
    Score: 0.135
  4. Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents. Pediatrics. 2023 05 01; 151(5).
    View in: PubMed
    Score: 0.134
  5. Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life. Nat Commun. 2023 Feb 28; 14(1):894.
    View in: PubMed
    Score: 0.132
  6. Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States. Ann Intern Med. 2022 12; 175(12):1169-1771.
    View in: PubMed
    Score: 0.129
  7. COVID-19 vaccination protects children and adolescents. Lancet Infect Dis. 2023 01; 23(1):5-6.
    View in: PubMed
    Score: 0.128
  8. Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in Utero. Pediatrics. 2022 07 01; 150(1).
    View in: PubMed
    Score: 0.126
  9. Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders. Vaccine. 2022 Apr 20; 40(18):2568-2573.
    View in: PubMed
    Score: 0.124
  10. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 04; 71(9):352-358.
    View in: PubMed
    Score: 0.123
  11. Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine. JAMA Netw Open. 2022 Mar 01; 5(3):e221111.
    View in: PubMed
    Score: 0.123
  12. Genetic associations with a fever after measles-containing vaccines. Hum Vaccin Immunother. 2021 06 03; 17(6):1763-1769.
    View in: PubMed
    Score: 0.114
  13. Shouting at each other into the void: A linguistic network analysis of vaccine hesitance and support in online discourse regarding California law SB277. Soc Sci Med. 2020 12; 266:113216.
    View in: PubMed
    Score: 0.111
  14. Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time. Hum Vaccin Immunother. 2020 12 01; 16(12):3098-3102.
    View in: PubMed
    Score: 0.109
  15. Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season. PLoS One. 2020; 15(2):e0229279.
    View in: PubMed
    Score: 0.107
  16. Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children. Hum Vaccin Immunother. 2020 08 02; 16(8):1753-1761.
    View in: PubMed
    Score: 0.107
  17. Parental risk factors for fever in their children 7-10 days after the first dose of measles-containing vaccines. Hum Vaccin Immunother. 2020 04 02; 16(4):875-880.
    View in: PubMed
    Score: 0.105
  18. Acellular Pertussis Vaccine Effectiveness Over Time. Pediatrics. 2019 07; 144(1).
    View in: PubMed
    Score: 0.102
  19. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study. Vaccine. 2018 04 19; 36(17):2356-2363.
    View in: PubMed
    Score: 0.094
  20. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children. Vaccine. 2018 04 12; 36(16):2133-2138.
    View in: PubMed
    Score: 0.094
  21. Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine. Vaccine. 2017 06 08; 35(26):3395-3400.
    View in: PubMed
    Score: 0.088
  22. Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines. Vaccine. 2017 05 09; 35(20):2668-2675.
    View in: PubMed
    Score: 0.088
  23. Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis. Clin Infect Dis. 2016 Dec 01; 63(11):1456-1462.
    View in: PubMed
    Score: 0.084
  24. Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children. Pediatr Infect Dis J. 2016 06; 35(6):662-72.
    View in: PubMed
    Score: 0.083
  25. Waning Tdap Effectiveness in Adolescents. Pediatrics. 2016 Mar; 137(3):e20153326.
    View in: PubMed
    Score: 0.081
  26. Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr. 2013 Dec; 167(12):1111-7.
    View in: PubMed
    Score: 0.070
  27. Long-term immune responses to pneumococcal conjugate vaccines in children previously vaccinated with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013 Sep; 32(9):990-7.
    View in: PubMed
    Score: 0.068
  28. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ. 2013 Jul 17; 347:f4249.
    View in: PubMed
    Score: 0.068
  29. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations. Sex Transm Dis. 2013 Jul; 40(7):534-8.
    View in: PubMed
    Score: 0.068
  30. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013 Jun; 131(6):e1716-22.
    View in: PubMed
    Score: 0.067
  31. Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis. 2013 Jul; 57(2):197-204.
    View in: PubMed
    Score: 0.067
  32. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1140-8.
    View in: PubMed
    Score: 0.065
  33. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012 Sep 13; 367(11):1012-9.
    View in: PubMed
    Score: 0.064
  34. Epidemiologic and clinical features of Bell's palsy among children in Northern California. Neuroepidemiology. 2012; 38(4):252-8.
    View in: PubMed
    Score: 0.063
  35. An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women. Vaccine. 2012 Jun 29; 30(31):4585-7.
    View in: PubMed
    Score: 0.063
  36. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14.
    View in: PubMed
    Score: 0.062
  37. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children. Vaccine. 2012 Jan 11; 30(3):668-74.
    View in: PubMed
    Score: 0.060
  38. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics. 2011 May; 127(5):e1139-46.
    View in: PubMed
    Score: 0.058
  39. Vaccine safety in special populations. Hum Vaccin. 2011 Feb; 7(2):269-71.
    View in: PubMed
    Score: 0.057
  40. Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization. Pediatr Infect Dis J. 2010 Jul; 29(7):613-7.
    View in: PubMed
    Score: 0.055
  41. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine. 2010 Jan 22; 28(4):1062-8.
    View in: PubMed
    Score: 0.053
  42. Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years. Expert Rev Vaccines. 2008 Nov; 7(9):1309-20.
    View in: PubMed
    Score: 0.049
  43. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Pediatr Infect Dis J. 2008 Apr; 27(4):341-6.
    View in: PubMed
    Score: 0.047
  44. A role for genetics in the immune response to the varicella vaccine. Pediatr Infect Dis J. 2007 Apr; 26(4):300-5.
    View in: PubMed
    Score: 0.044
  45. Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study. JMIR Public Health Surveill. 2024 Jun 25; 10:e53807.
    View in: PubMed
    Score: 0.036
  46. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. MMWR Morb Mortal Wkly Rep. 2024 Feb 29; 73(8):168-174.
    View in: PubMed
    Score: 0.035
  47. Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 18; 72(33):886-892.
    View in: PubMed
    Score: 0.034
  48. Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 Study. Pediatrics. 2023 Jul 01; 152(1).
    View in: PubMed
    Score: 0.034
  49. Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):273-281.
    View in: PubMed
    Score: 0.034
  50. Extended surveillance to assess safety of 9-valent human papillomavirus vaccine. Hum Vaccin Immunother. 2022 12 30; 18(7):2159215.
    View in: PubMed
    Score: 0.033
  51. Characterization of parental intention to vaccinate elementary school aged children in the state of California. Vaccine. 2023 01 16; 41(3):630-635.
    View in: PubMed
    Score: 0.033
  52. Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months. Acad Pediatr. 2023 Jan-Feb; 23(1):37-46.
    View in: PubMed
    Score: 0.032
  53. Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018. Epidemiol Infect. 2022 02 24; 150:e85.
    View in: PubMed
    Score: 0.031
  54. Evaluation of Trends in Homeschooling Rates After Elimination of Nonmedical Exemptions to Childhood Immunizations in California, 2012-2020. JAMA Netw Open. 2022 02 01; 5(2):e2146467.
    View in: PubMed
    Score: 0.031
  55. Association of the COVID-19 Pandemic With Routine Childhood Vaccination Rates and Proportion Up to Date With Vaccinations Across 8 US Health Systems in the Vaccine Safety Datalink. JAMA Pediatr. 2022 01 01; 176(1):68-77.
    View in: PubMed
    Score: 0.031
  56. The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes. Pediatrics. 2021 12 01; 148(6).
    View in: PubMed
    Score: 0.030
  57. COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 29; 70(43):1520-1524.
    View in: PubMed
    Score: 0.030
  58. City-wide school-located influenza vaccination: A retrospective cohort study. Vaccine. 2021 10 08; 39(42):6302-6307.
    View in: PubMed
    Score: 0.030
  59. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 07 15; 385(3):239-250.
    View in: PubMed
    Score: 0.029
  60. Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine. 2021 06 16; 39(27):3614-3620.
    View in: PubMed
    Score: 0.029
  61. Temporal Trends in Undervaccination: A Population-Based Cohort Study. Am J Prev Med. 2021 07; 61(1):64-72.
    View in: PubMed
    Score: 0.029
  62. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):141-150.
    View in: PubMed
    Score: 0.029
  63. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021 05 21; 39(22):3037-3049.
    View in: PubMed
    Score: 0.029
  64. Parental vaccine attitudes, beliefs, and practices: initial evidence in California after a vaccine policy change. Hum Vaccin Immunother. 2021 06 03; 17(6):1675-1680.
    View in: PubMed
    Score: 0.028
  65. Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial. Vaccine. 2021 03 05; 39(10):1534-1543.
    View in: PubMed
    Score: 0.028
  66. Association Between Rotavirus Vaccination and Type 1 Diabetes in Children. JAMA Pediatr. 2020 05 01; 174(5):455-462.
    View in: PubMed
    Score: 0.027
  67. Homeschooling parents in California: Attitudes, beliefs and behaviors associated with child's vaccination status. Vaccine. 2020 02 18; 38(8):1899-1905.
    View in: PubMed
    Score: 0.027
  68. Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics. 2019 12; 144(6).
    View in: PubMed
    Score: 0.026
  69. Associations of Statewide Legislative and Administrative Interventions With Vaccination Status Among Kindergartners in California. JAMA. 2019 07 02; 322(1):49-56.
    View in: PubMed
    Score: 0.026
  70. Incidence of Herpes Zoster Among Children: 2003-2014. Pediatrics. 2019 07; 144(1).
    View in: PubMed
    Score: 0.026
  71. Elimination of Nonmedical Immunization Exemptions in California and School-Entry Vaccine Status. Pediatrics. 2019 06; 143(6).
    View in: PubMed
    Score: 0.025
  72. Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study. Vaccine. 2018 10 01; 36(41):6111-6116.
    View in: PubMed
    Score: 0.024
  73. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine. Vaccine. 2017 12 14; 35(49 Pt B):6879-6884.
    View in: PubMed
    Score: 0.023
  74. Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011. Vaccine. 2016 Jan 02; 34(1):167-71.
    View in: PubMed
    Score: 0.020
  75. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016 Mar; 137(3):868-78.
    View in: PubMed
    Score: 0.020
  76. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Pediatr Infect Dis J. 2015 Sep; 34(9):983-91.
    View in: PubMed
    Score: 0.020
  77. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006. Vaccine. 2015 Jan 03; 33(2):382-7.
    View in: PubMed
    Score: 0.019
  78. Does preventing rotavirus infections through vaccination also protect against naturally occurring intussusception over time? Clin Infect Dis. 2015 Jan 01; 60(1):163-4.
    View in: PubMed
    Score: 0.018
  79. Live vaccine use and safety in DiGeorge syndrome. Pediatrics. 2014 Apr; 133(4):e946-54.
    View in: PubMed
    Score: 0.018
  80. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
    View in: PubMed
    Score: 0.018
  81. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med. 2014 Feb; 46(2):150-7.
    View in: PubMed
    Score: 0.018
  82. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis. 2014 Jan; 58(2):173-7.
    View in: PubMed
    Score: 0.017
  83. Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005. Cancer Epidemiol Biomarkers Prev. 2013 Jun; 22(6):1129-32.
    View in: PubMed
    Score: 0.017
  84. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J. 2013 Feb; 32(2):163-8.
    View in: PubMed
    Score: 0.016
  85. Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact. Cancer Causes Control. 2013 Feb; 24(2):403-7.
    View in: PubMed
    Score: 0.016
  86. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2012 Nov 26; 30(50):7253-9.
    View in: PubMed
    Score: 0.016
  87. Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol. 2012 May 01; 175(9):878-85.
    View in: PubMed
    Score: 0.015
  88. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
    View in: PubMed
    Score: 0.015
  89. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine. 2011 Oct 26; 29(46):8279-84.
    View in: PubMed
    Score: 0.015
  90. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine. 2011 Oct 26; 29(46):8302-8.
    View in: PubMed
    Score: 0.015
  91. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics. 2011 May; 127 Suppl 1:S54-64.
    View in: PubMed
    Score: 0.015
  92. Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age. Vaccine. 2010 Nov 23; 28(50):7865-72.
    View in: PubMed
    Score: 0.014
  93. Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age. Vaccine. 2010 Jan 08; 28(3):657-63.
    View in: PubMed
    Score: 0.013
  94. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009 Oct; 99 Suppl 2:S389-97.
    View in: PubMed
    Score: 0.013
  95. Varicella vaccination and ischemic stroke in children: is there an association? Pediatrics. 2009 Feb; 123(2):e228-34.
    View in: PubMed
    Score: 0.012

© 2024 Kaiser Permanente